| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |